PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general.
| Website | https://www.pantera-life.com |
| Employees | 68 (40 on RocketReach) |
| Founded | 2022 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Radioisotope Production, Radiopharmaceutical Manufacturing, Nuclear Medicine, Isotope Separation, Nuclear Medicine Technology, Cancer Treatment, Radioactive Materials, Medical Isotopes, Radiotherapy, Pharmaceutical Manufacturing, Cancer Therapy, Drug Development, Oncology, Clinical Trials |
| Competitors | Trulieve, Cresco Labs, Curaleaf, Green Thumb Industries (GTI), Tilray Brands, Inc., Canopy Growth Corporation, MedMen, Hexo, Aphria, Harvest HOC +33 more (view full list) |
Looking for a particular PANTERA employee's phone or email?
PANTERA Questions
Sven van Den Berghe is the CEO of PANTERA.
40 people are employed at PANTERA.
Top PANTERA Employees
-
1
-
Samy Bertrand
CTO at PANTERA
Brussels, Belgium2 -
Christophe Malice
Chief Business Officer at PANTERA
Brussels, BE1 -
1
-
Tinne Withofs
Building project manager at PANTERA
Herentals, BE1 -
1
G2Crowd Trusted
300K+
Plugin Users
